▶ 調査レポート

世界の非侵襲的連続血糖モニター市場インサイト・予測(~2027年)

• 英文タイトル:Global Non-invasive Continuous Glucose Monitor Market Insights and Forecast to 2027

QYResearchが調査・発行した産業分析レポートです。世界の非侵襲的連続血糖モニター市場インサイト・予測(~2027年) / Global Non-invasive Continuous Glucose Monitor Market Insights and Forecast to 2027 / QY2108PAL3632資料のイメージです。• レポートコード:QY2108PAL3632
• 出版社/出版日:QYResearch / 2021年8月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、106ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User¥725,200 (USD4,900)▷ お問い合わせ
  Multi User¥1,087,800 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,450,400 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査資料は非侵襲的連続血糖モニターの世界市場の現状について調査・分析し、2027年までの市場を予測しました。非侵襲的連続血糖モニターの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模(ウェアラブル、非ウェアラブル)、用途別市場規模(病院、クリニック、その他)、主要地域別市場規模(北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ)、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。

・非侵襲的連続血糖モニターの世界市場概要
・メーカー別の競争状況、市場シェア
・非侵襲的連続血糖モニターの種類別市場規模:ウェアラブル、非ウェアラブル
・非侵襲的連続血糖モニターの用途別市場規模:病院、クリニック、その他
・北米の非侵襲的連続血糖モニター市場規模2016-2027:種類別、用途別、国別(アメリカ、カナダ)
・ヨーロッパの非侵襲的連続血糖モニター市場規模2016-2027:種類別、用途別、国別(ドイツ、フランス、イギリス)
・アジアの非侵襲的連続血糖モニター市場規模2016-2027:種類別、用途別、国別(日本、中国、インド、韓国)
・中南米の非侵襲的連続血糖モニター市場規模2016-2027:種類別、用途別、国別(メキシコ、ブラジル)
・中東・アフリカの非侵襲的連続血糖モニター市場規模2016-2027:種類別、用途別、国別(トルコ、サウジアラビア)
・企業情報:Dexcom、Abbott Laboratories、Medtronic、Senseonics Holdings、Know Labs、Huzhou Meiqi Medical Devices、San Meditech、Roche、LifeScan, Inc.、Insulet Corporation、Panasonic、Echo Therapeutics、Tandem Diabetes Care
・非侵襲的連続血糖モニターのバリューチェーン・販売チャネル分析
・非侵襲的連続血糖モニターの世界市場動向

Market Analysis and Insights: Global Non-invasive Continuous Glucose Monitor Market
The global Non-invasive Continuous Glucose Monitor market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Non-invasive Continuous Glucose Monitor Scope and Segment
Non-invasive Continuous Glucose Monitor market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Non-invasive Continuous Glucose Monitor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Wearable
Not wearable

Segment by Application
Hospital
Clinic
Other

By Company
Dexcom
Abbott Laboratories
Medtronic
Senseonics Holdings
Know Labs
Huzhou Meiqi Medical Devices
San Meditech
Roche
LifeScan, Inc.
Insulet Corporation
Panasonic
Echo Therapeutics
Tandem Diabetes Care

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Non-invasive Continuous Glucose Monitor Product Introduction
1.2 Market by Type
1.2.1 Global Non-invasive Continuous Glucose Monitor Market Size Growth Rate by Type
1.2.2 Wearable
1.2.3 Not wearable
1.3 Market by Application
1.3.1 Global Non-invasive Continuous Glucose Monitor Market Size Growth Rate by Application
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Non-invasive Continuous Glucose Monitor Sales Estimates and Forecasts 2016-2027
2.2 Global Non-invasive Continuous Glucose Monitor Revenue Estimates and Forecasts 2016-2027
2.3 Global Non-invasive Continuous Glucose Monitor Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Non-invasive Continuous Glucose Monitor Regions by Sales
2.4.1 Global Top Non-invasive Continuous Glucose Monitor Regions by Sales (2016-2021)
2.4.2 Global Top Non-invasive Continuous Glucose Monitor Regions by Sales (2022-2027)
2.5 Global Top Non-invasive Continuous Glucose Monitor Regions by Revenue
2.5.1 Global Top Non-invasive Continuous Glucose Monitor Regions by Revenue (2016-2021)
2.5.2 Global Top Non-invasive Continuous Glucose Monitor Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa

3 Competition by Manufacturers
3.1 Global Non-invasive Continuous Glucose Monitor Sales by Manufacturers
3.1.1 Global Top Non-invasive Continuous Glucose Monitor Manufacturers by Sales (2016-2021)
3.1.2 Global Top Non-invasive Continuous Glucose Monitor Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Non-invasive Continuous Glucose Monitor Sales in 2020
3.2 Global Non-invasive Continuous Glucose Monitor Revenue by Manufacturers
3.2.1 Global Top Non-invasive Continuous Glucose Monitor Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Non-invasive Continuous Glucose Monitor Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Non-invasive Continuous Glucose Monitor Revenue in 2020
3.3 Global Non-invasive Continuous Glucose Monitor Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Non-invasive Continuous Glucose Monitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Non-invasive Continuous Glucose Monitor Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Non-invasive Continuous Glucose Monitor Sales by Type
4.1.1 Global Non-invasive Continuous Glucose Monitor Historical Sales by Type (2016-2021)
4.1.2 Global Non-invasive Continuous Glucose Monitor Forecasted Sales by Type (2022-2027)
4.1.3 Global Non-invasive Continuous Glucose Monitor Sales Market Share by Type (2016-2027)
4.2 Global Non-invasive Continuous Glucose Monitor Revenue by Type
4.2.1 Global Non-invasive Continuous Glucose Monitor Historical Revenue by Type (2016-2021)
4.2.2 Global Non-invasive Continuous Glucose Monitor Forecasted Revenue by Type (2022-2027)
4.2.3 Global Non-invasive Continuous Glucose Monitor Revenue Market Share by Type (2016-2027)
4.3 Global Non-invasive Continuous Glucose Monitor Price by Type
4.3.1 Global Non-invasive Continuous Glucose Monitor Price by Type (2016-2021)
4.3.2 Global Non-invasive Continuous Glucose Monitor Price Forecast by Type (2022-2027)

5 Market Size by Application
5.1 Global Non-invasive Continuous Glucose Monitor Sales by Application
5.1.1 Global Non-invasive Continuous Glucose Monitor Historical Sales by Application (2016-2021)
5.1.2 Global Non-invasive Continuous Glucose Monitor Forecasted Sales by Application (2022-2027)
5.1.3 Global Non-invasive Continuous Glucose Monitor Sales Market Share by Application (2016-2027)
5.2 Global Non-invasive Continuous Glucose Monitor Revenue by Application
5.2.1 Global Non-invasive Continuous Glucose Monitor Historical Revenue by Application (2016-2021)
5.2.2 Global Non-invasive Continuous Glucose Monitor Forecasted Revenue by Application (2022-2027)
5.2.3 Global Non-invasive Continuous Glucose Monitor Revenue Market Share by Application (2016-2027)
5.3 Global Non-invasive Continuous Glucose Monitor Price by Application
5.3.1 Global Non-invasive Continuous Glucose Monitor Price by Application (2016-2021)
5.3.2 Global Non-invasive Continuous Glucose Monitor Price Forecast by Application (2022-2027)

6 North America
6.1 North America Non-invasive Continuous Glucose Monitor Market Size by Type
6.1.1 North America Non-invasive Continuous Glucose Monitor Sales by Type (2016-2027)
6.1.2 North America Non-invasive Continuous Glucose Monitor Revenue by Type (2016-2027)
6.2 North America Non-invasive Continuous Glucose Monitor Market Size by Application
6.2.1 North America Non-invasive Continuous Glucose Monitor Sales by Application (2016-2027)
6.2.2 North America Non-invasive Continuous Glucose Monitor Revenue by Application (2016-2027)
6.3 North America Non-invasive Continuous Glucose Monitor Market Size by Country
6.3.1 North America Non-invasive Continuous Glucose Monitor Sales by Country (2016-2027)
6.3.2 North America Non-invasive Continuous Glucose Monitor Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada

7 Europe
7.1 Europe Non-invasive Continuous Glucose Monitor Market Size by Type
7.1.1 Europe Non-invasive Continuous Glucose Monitor Sales by Type (2016-2027)
7.1.2 Europe Non-invasive Continuous Glucose Monitor Revenue by Type (2016-2027)
7.2 Europe Non-invasive Continuous Glucose Monitor Market Size by Application
7.2.1 Europe Non-invasive Continuous Glucose Monitor Sales by Application (2016-2027)
7.2.2 Europe Non-invasive Continuous Glucose Monitor Revenue by Application (2016-2027)
7.3 Europe Non-invasive Continuous Glucose Monitor Market Size by Country
7.3.1 Europe Non-invasive Continuous Glucose Monitor Sales by Country (2016-2027)
7.3.2 Europe Non-invasive Continuous Glucose Monitor Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia

8 Asia Pacific
8.1 Asia Pacific Non-invasive Continuous Glucose Monitor Market Size by Type
8.1.1 Asia Pacific Non-invasive Continuous Glucose Monitor Sales by Type (2016-2027)
8.1.2 Asia Pacific Non-invasive Continuous Glucose Monitor Revenue by Type (2016-2027)
8.2 Asia Pacific Non-invasive Continuous Glucose Monitor Market Size by Application
8.2.1 Asia Pacific Non-invasive Continuous Glucose Monitor Sales by Application (2016-2027)
8.2.2 Asia Pacific Non-invasive Continuous Glucose Monitor Revenue by Application (2016-2027)
8.3 Asia Pacific Non-invasive Continuous Glucose Monitor Market Size by Region
8.3.1 Asia Pacific Non-invasive Continuous Glucose Monitor Sales by Region (2016-2027)
8.3.2 Asia Pacific Non-invasive Continuous Glucose Monitor Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia

9 Latin America
9.1 Latin America Non-invasive Continuous Glucose Monitor Market Size by Type
9.1.1 Latin America Non-invasive Continuous Glucose Monitor Sales by Type (2016-2027)
9.1.2 Latin America Non-invasive Continuous Glucose Monitor Revenue by Type (2016-2027)
9.2 Latin America Non-invasive Continuous Glucose Monitor Market Size by Application
9.2.1 Latin America Non-invasive Continuous Glucose Monitor Sales by Application (2016-2027)
9.2.2 Latin America Non-invasive Continuous Glucose Monitor Revenue by Application (2016-2027)
9.3 Latin America Non-invasive Continuous Glucose Monitor Market Size by Country
9.3.1 Latin America Non-invasive Continuous Glucose Monitor Sales by Country (2016-2027)
9.3.2 Latin America Non-invasive Continuous Glucose Monitor Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia

10 Middle East and Africa
10.1 Middle East and Africa Non-invasive Continuous Glucose Monitor Market Size by Type
10.1.1 Middle East and Africa Non-invasive Continuous Glucose Monitor Sales by Type (2016-2027)
10.1.2 Middle East and Africa Non-invasive Continuous Glucose Monitor Revenue by Type (2016-2027)
10.2 Middle East and Africa Non-invasive Continuous Glucose Monitor Market Size by Application
10.2.1 Middle East and Africa Non-invasive Continuous Glucose Monitor Sales by Application (2016-2027)
10.2.2 Middle East and Africa Non-invasive Continuous Glucose Monitor Revenue by Application (2016-2027)
10.3 Middle East and Africa Non-invasive Continuous Glucose Monitor Market Size by Country
10.3.1 Middle East and Africa Non-invasive Continuous Glucose Monitor Sales by Country (2016-2027)
10.3.2 Middle East and Africa Non-invasive Continuous Glucose Monitor Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia

11 Company Profiles
11.1 Dexcom
11.1.1 Dexcom Corporation Information
11.1.2 Dexcom Overview
11.1.3 Dexcom Non-invasive Continuous Glucose Monitor Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Dexcom Non-invasive Continuous Glucose Monitor Product Description
11.1.5 Dexcom Recent Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Corporation Information
11.2.2 Abbott Laboratories Overview
11.2.3 Abbott Laboratories Non-invasive Continuous Glucose Monitor Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Abbott Laboratories Non-invasive Continuous Glucose Monitor Product Description
11.2.5 Abbott Laboratories Recent Developments
11.3 Medtronic
11.3.1 Medtronic Corporation Information
11.3.2 Medtronic Overview
11.3.3 Medtronic Non-invasive Continuous Glucose Monitor Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Medtronic Non-invasive Continuous Glucose Monitor Product Description
11.3.5 Medtronic Recent Developments
11.4 Senseonics Holdings
11.4.1 Senseonics Holdings Corporation Information
11.4.2 Senseonics Holdings Overview
11.4.3 Senseonics Holdings Non-invasive Continuous Glucose Monitor Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Senseonics Holdings Non-invasive Continuous Glucose Monitor Product Description
11.4.5 Senseonics Holdings Recent Developments
11.5 Know Labs
11.5.1 Know Labs Corporation Information
11.5.2 Know Labs Overview
11.5.3 Know Labs Non-invasive Continuous Glucose Monitor Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Know Labs Non-invasive Continuous Glucose Monitor Product Description
11.5.5 Know Labs Recent Developments
11.6 Huzhou Meiqi Medical Devices
11.6.1 Huzhou Meiqi Medical Devices Corporation Information
11.6.2 Huzhou Meiqi Medical Devices Overview
11.6.3 Huzhou Meiqi Medical Devices Non-invasive Continuous Glucose Monitor Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Huzhou Meiqi Medical Devices Non-invasive Continuous Glucose Monitor Product Description
11.6.5 Huzhou Meiqi Medical Devices Recent Developments
11.7 San Meditech
11.7.1 San Meditech Corporation Information
11.7.2 San Meditech Overview
11.7.3 San Meditech Non-invasive Continuous Glucose Monitor Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 San Meditech Non-invasive Continuous Glucose Monitor Product Description
11.7.5 San Meditech Recent Developments
11.8 Roche
11.8.1 Roche Corporation Information
11.8.2 Roche Overview
11.8.3 Roche Non-invasive Continuous Glucose Monitor Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Roche Non-invasive Continuous Glucose Monitor Product Description
11.8.5 Roche Recent Developments
11.9 LifeScan, Inc.
11.9.1 LifeScan, Inc. Corporation Information
11.9.2 LifeScan, Inc. Overview
11.9.3 LifeScan, Inc. Non-invasive Continuous Glucose Monitor Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 LifeScan, Inc. Non-invasive Continuous Glucose Monitor Product Description
11.9.5 LifeScan, Inc. Recent Developments
11.10 Insulet Corporation
11.10.1 Insulet Corporation Corporation Information
11.10.2 Insulet Corporation Overview
11.10.3 Insulet Corporation Non-invasive Continuous Glucose Monitor Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Insulet Corporation Non-invasive Continuous Glucose Monitor Product Description
11.10.5 Insulet Corporation Recent Developments
11.11 Panasonic
11.11.1 Panasonic Corporation Information
11.11.2 Panasonic Overview
11.11.3 Panasonic Non-invasive Continuous Glucose Monitor Sales, Price, Revenue and Gross Margin (2016-2021)
11.11.4 Panasonic Non-invasive Continuous Glucose Monitor Product Description
11.11.5 Panasonic Recent Developments
11.12 Echo Therapeutics
11.12.1 Echo Therapeutics Corporation Information
11.12.2 Echo Therapeutics Overview
11.12.3 Echo Therapeutics Non-invasive Continuous Glucose Monitor Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 Echo Therapeutics Non-invasive Continuous Glucose Monitor Product Description
11.12.5 Echo Therapeutics Recent Developments
11.13 Tandem Diabetes Care
11.13.1 Tandem Diabetes Care Corporation Information
11.13.2 Tandem Diabetes Care Overview
11.13.3 Tandem Diabetes Care Non-invasive Continuous Glucose Monitor Sales, Price, Revenue and Gross Margin (2016-2021)
11.13.4 Tandem Diabetes Care Non-invasive Continuous Glucose Monitor Product Description
11.13.5 Tandem Diabetes Care Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Non-invasive Continuous Glucose Monitor Value Chain Analysis
12.2 Non-invasive Continuous Glucose Monitor Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Non-invasive Continuous Glucose Monitor Production Mode & Process
12.4 Non-invasive Continuous Glucose Monitor Sales and Marketing
12.4.1 Non-invasive Continuous Glucose Monitor Sales Channels
12.4.2 Non-invasive Continuous Glucose Monitor Distributors
12.5 Non-invasive Continuous Glucose Monitor Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Non-invasive Continuous Glucose Monitor Industry Trends
13.2 Non-invasive Continuous Glucose Monitor Market Drivers
13.3 Non-invasive Continuous Glucose Monitor Market Challenges
13.4 Non-invasive Continuous Glucose Monitor Market Restraints

14 Key Findings in The Global Non-invasive Continuous Glucose Monitor Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Non-invasive Continuous Glucose Monitor Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Wearable
Table 3. Major Manufacturers of Not wearable
Table 4. Global Non-invasive Continuous Glucose Monitor Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Non-invasive Continuous Glucose Monitor Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Non-invasive Continuous Glucose Monitor Sales by Region (2016-2021) & (K Units)
Table 7. Global Non-invasive Continuous Glucose Monitor Sales Market Share by Region (2016-2021)
Table 8. Global Non-invasive Continuous Glucose Monitor Sales by Region (2022-2027) & (K Units)
Table 9. Global Non-invasive Continuous Glucose Monitor Sales Market Share by Region (2022-2027)
Table 10. Global Non-invasive Continuous Glucose Monitor Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Non-invasive Continuous Glucose Monitor Revenue Market Share by Region (2016-2021)
Table 12. Global Non-invasive Continuous Glucose Monitor Revenue by Region (2022-2027) & (US$ Million)
Table 13. Global Non-invasive Continuous Glucose Monitor Revenue Market Share by Region (2022-2027)
Table 14. Global Non-invasive Continuous Glucose Monitor Sales by Manufacturers (2016-2021) & (K Units)
Table 15. Global Non-invasive Continuous Glucose Monitor Sales Share by Manufacturers (2016-2021)
Table 16. Global Non-invasive Continuous Glucose Monitor Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 17. Global Non-invasive Continuous Glucose Monitor Revenue Share by Manufacturers (2016-2021)
Table 18. Non-invasive Continuous Glucose Monitor Price by Manufacturers 2016-2021 (US$/Unit)
Table 19. Global Non-invasive Continuous Glucose Monitor Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Non-invasive Continuous Glucose Monitor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-invasive Continuous Glucose Monitor as of 2020)
Table 21. Non-invasive Continuous Glucose Monitor Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Non-invasive Continuous Glucose Monitor Product Offered
Table 23. Date of Manufacturers Enter into Non-invasive Continuous Glucose Monitor Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Non-invasive Continuous Glucose Monitor Sales by Type (2016-2021) & (K Units)
Table 26. Global Non-invasive Continuous Glucose Monitor Sales by Type (2022-2027) & (K Units)
Table 27. Global Non-invasive Continuous Glucose Monitor Sales Share by Type (2016-2021)
Table 28. Global Non-invasive Continuous Glucose Monitor Sales Share by Type (2022-2027)
Table 29. Global Non-invasive Continuous Glucose Monitor Revenue by Type (2016-2021) & (US$ Million)
Table 30. Global Non-invasive Continuous Glucose Monitor Revenue by Type (2022-2027) & (US$ Million)
Table 31. Global Non-invasive Continuous Glucose Monitor Revenue Share by Type (2016-2021)
Table 32. Global Non-invasive Continuous Glucose Monitor Revenue Share by Type (2022-2027)
Table 33. Non-invasive Continuous Glucose Monitor Price by Type (2016-2021) & (US$/Unit)
Table 34. Global Non-invasive Continuous Glucose Monitor Price Forecast by Type (2022-2027) & (US$/Unit)
Table 35. Global Non-invasive Continuous Glucose Monitor Sales by Application (2016-2021) & (K Units)
Table 36. Global Non-invasive Continuous Glucose Monitor Sales by Application (2022-2027) & (K Units)
Table 37. Global Non-invasive Continuous Glucose Monitor Sales Share by Application (2016-2021)
Table 38. Global Non-invasive Continuous Glucose Monitor Sales Share by Application (2022-2027)
Table 39. Global Non-invasive Continuous Glucose Monitor Revenue by Application (2016-2021) & (US$ Million)
Table 40. Global Non-invasive Continuous Glucose Monitor Revenue by Application (2022-2027) & (US$ Million)
Table 41. Global Non-invasive Continuous Glucose Monitor Revenue Share by Application (2016-2021)
Table 42. Global Non-invasive Continuous Glucose Monitor Revenue Share by Application (2022-2027)
Table 43. Non-invasive Continuous Glucose Monitor Price by Application (2016-2021) & (US$/Unit)
Table 44. Global Non-invasive Continuous Glucose Monitor Price Forecast by Application (2022-2027) & (US$/Unit)
Table 45. North America Non-invasive Continuous Glucose Monitor Sales by Type (2016-2021) & (K Units)
Table 46. North America Non-invasive Continuous Glucose Monitor Sales by Type (2022-2027) & (K Units)
Table 47. North America Non-invasive Continuous Glucose Monitor Revenue by Type (2016-2021) & (US$ Million)
Table 48. North America Non-invasive Continuous Glucose Monitor Revenue by Type (2022-2027) & (US$ Million)
Table 49. North America Non-invasive Continuous Glucose Monitor Sales by Application (2016-2021) & (K Units)
Table 50. North America Non-invasive Continuous Glucose Monitor Sales by Application (2022-2027) & (K Units)
Table 51. North America Non-invasive Continuous Glucose Monitor Revenue by Application (2016-2021) & (US$ Million)
Table 52. North America Non-invasive Continuous Glucose Monitor Revenue by Application (2022-2027) & (US$ Million)
Table 53. North America Non-invasive Continuous Glucose Monitor Sales by Country (2016-2021) & (K Units)
Table 54. North America Non-invasive Continuous Glucose Monitor Sales by Country (2022-2027) & (K Units)
Table 55. North America Non-invasive Continuous Glucose Monitor Revenue by Country (2016-2021) & (US$ Million)
Table 56. North America Non-invasive Continuous Glucose Monitor Revenue by Country (2022-2027) & (US$ Million)
Table 57. Europe Non-invasive Continuous Glucose Monitor Sales by Type (2016-2021) & (K Units)
Table 58. Europe Non-invasive Continuous Glucose Monitor Sales by Type (2022-2027) & (K Units)
Table 59. Europe Non-invasive Continuous Glucose Monitor Revenue by Type (2016-2021) & (US$ Million)
Table 60. Europe Non-invasive Continuous Glucose Monitor Revenue by Type (2022-2027) & (US$ Million)
Table 61. Europe Non-invasive Continuous Glucose Monitor Sales by Application (2016-2021) & (K Units)
Table 62. Europe Non-invasive Continuous Glucose Monitor Sales by Application (2022-2027) & (K Units)
Table 63. Europe Non-invasive Continuous Glucose Monitor Revenue by Application (2016-2021) & (US$ Million)
Table 64. Europe Non-invasive Continuous Glucose Monitor Revenue by Application (2022-2027) & (US$ Million)
Table 65. Europe Non-invasive Continuous Glucose Monitor Sales by Country (2016-2021) & (K Units)
Table 66. Europe Non-invasive Continuous Glucose Monitor Sales by Country (2022-2027) & (K Units)
Table 67. Europe Non-invasive Continuous Glucose Monitor Revenue by Country (2016-2021) & (US$ Million)
Table 68. Europe Non-invasive Continuous Glucose Monitor Revenue by Country (2022-2027) & (US$ Million)
Table 69. Asia Pacific Non-invasive Continuous Glucose Monitor Sales by Type (2016-2021) & (K Units)
Table 70. Asia Pacific Non-invasive Continuous Glucose Monitor Sales by Type (2022-2027) & (K Units)
Table 71. Asia Pacific Non-invasive Continuous Glucose Monitor Revenue by Type (2016-2021) & (US$ Million)
Table 72. Asia Pacific Non-invasive Continuous Glucose Monitor Revenue by Type (2022-2027) & (US$ Million)
Table 73. Asia Pacific Non-invasive Continuous Glucose Monitor Sales by Application (2016-2021) & (K Units)
Table 74. Asia Pacific Non-invasive Continuous Glucose Monitor Sales by Application (2022-2027) & (K Units)
Table 75. Asia Pacific Non-invasive Continuous Glucose Monitor Revenue by Application (2016-2021) & (US$ Million)
Table 76. Asia Pacific Non-invasive Continuous Glucose Monitor Revenue by Application (2022-2027) & (US$ Million)
Table 77. Asia Pacific Non-invasive Continuous Glucose Monitor Sales by Region (2016-2021) & (K Units)
Table 78. Asia Pacific Non-invasive Continuous Glucose Monitor Sales by Region (2022-2027) & (K Units)
Table 79. Asia Pacific Non-invasive Continuous Glucose Monitor Revenue by Region (2016-2021) & (US$ Million)
Table 80. Asia Pacific Non-invasive Continuous Glucose Monitor Revenue by Region (2022-2027) & (US$ Million)
Table 81. Latin America Non-invasive Continuous Glucose Monitor Sales by Type (2016-2021) & (K Units)
Table 82. Latin America Non-invasive Continuous Glucose Monitor Sales by Type (2022-2027) & (K Units)
Table 83. Latin America Non-invasive Continuous Glucose Monitor Revenue by Type (2016-2021) & (US$ Million)
Table 84. Latin America Non-invasive Continuous Glucose Monitor Revenue by Type (2022-2027) & (US$ Million)
Table 85. Latin America Non-invasive Continuous Glucose Monitor Sales by Application (2016-2021) & (K Units)
Table 86. Latin America Non-invasive Continuous Glucose Monitor Sales by Application (2022-2027) & (K Units)
Table 87. Latin America Non-invasive Continuous Glucose Monitor Revenue by Application (2016-2021) & (US$ Million)
Table 88. Latin America Non-invasive Continuous Glucose Monitor Revenue by Application (2022-2027) & (US$ Million)
Table 89. Latin America Non-invasive Continuous Glucose Monitor Sales by Country (2016-2021) & (K Units)
Table 90. Latin America Non-invasive Continuous Glucose Monitor Sales by Country (2022-2027) & (K Units)
Table 91. Latin America Non-invasive Continuous Glucose Monitor Revenue by Country (2016-2021) & (US$ Million)
Table 92. Latin America Non-invasive Continuous Glucose Monitor Revenue by Country (2022-2027) & (US$ Million)
Table 93. Middle East and Africa Non-invasive Continuous Glucose Monitor Sales by Type (2016-2021) & (K Units)
Table 94. Middle East and Africa Non-invasive Continuous Glucose Monitor Sales by Type (2022-2027) & (K Units)
Table 95. Middle East and Africa Non-invasive Continuous Glucose Monitor Revenue by Type (2016-2021) & (US$ Million)
Table 96. Middle East and Africa Non-invasive Continuous Glucose Monitor Revenue by Type (2022-2027) & (US$ Million)
Table 97. Middle East and Africa Non-invasive Continuous Glucose Monitor Sales by Application (2016-2021) & (K Units)
Table 98. Middle East and Africa Non-invasive Continuous Glucose Monitor Sales by Application (2022-2027) & (K Units)
Table 99. Middle East and Africa Non-invasive Continuous Glucose Monitor Revenue by Application (2016-2021) & (US$ Million)
Table 100. Middle East and Africa Non-invasive Continuous Glucose Monitor Revenue by Application (2022-2027) & (US$ Million)
Table 101. Middle East and Africa Non-invasive Continuous Glucose Monitor Sales by Country (2016-2021) & (K Units)
Table 102. Middle East and Africa Non-invasive Continuous Glucose Monitor Sales by Country (2022-2027) & (K Units)
Table 103. Middle East and Africa Non-invasive Continuous Glucose Monitor Revenue by Country (2016-2021) & (US$ Million)
Table 104. Middle East and Africa Non-invasive Continuous Glucose Monitor Revenue by Country (2022-2027) & (US$ Million)
Table 105. Dexcom Corporation Information
Table 106. Dexcom Description and Major Businesses
Table 107. Dexcom Non-invasive Continuous Glucose Monitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 108. Dexcom Non-invasive Continuous Glucose Monitor Product
Table 109. Dexcom Recent Developments
Table 110. Abbott Laboratories Corporation Information
Table 111. Abbott Laboratories Description and Major Businesses
Table 112. Abbott Laboratories Non-invasive Continuous Glucose Monitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 113. Abbott Laboratories Non-invasive Continuous Glucose Monitor Product
Table 114. Abbott Laboratories Recent Developments
Table 115. Medtronic Corporation Information
Table 116. Medtronic Description and Major Businesses
Table 117. Medtronic Non-invasive Continuous Glucose Monitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 118. Medtronic Non-invasive Continuous Glucose Monitor Product
Table 119. Medtronic Recent Developments
Table 120. Senseonics Holdings Corporation Information
Table 121. Senseonics Holdings Description and Major Businesses
Table 122. Senseonics Holdings Non-invasive Continuous Glucose Monitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 123. Senseonics Holdings Non-invasive Continuous Glucose Monitor Product
Table 124. Senseonics Holdings Recent Developments
Table 125. Know Labs Corporation Information
Table 126. Know Labs Description and Major Businesses
Table 127. Know Labs Non-invasive Continuous Glucose Monitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 128. Know Labs Non-invasive Continuous Glucose Monitor Product
Table 129. Know Labs Recent Developments
Table 130. Huzhou Meiqi Medical Devices Corporation Information
Table 131. Huzhou Meiqi Medical Devices Description and Major Businesses
Table 132. Huzhou Meiqi Medical Devices Non-invasive Continuous Glucose Monitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 133. Huzhou Meiqi Medical Devices Non-invasive Continuous Glucose Monitor Product
Table 134. Huzhou Meiqi Medical Devices Recent Developments
Table 135. San Meditech Corporation Information
Table 136. San Meditech Description and Major Businesses
Table 137. San Meditech Non-invasive Continuous Glucose Monitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 138. San Meditech Non-invasive Continuous Glucose Monitor Product
Table 139. San Meditech Recent Developments
Table 140. Roche Corporation Information
Table 141. Roche Description and Major Businesses
Table 142. Roche Non-invasive Continuous Glucose Monitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 143. Roche Non-invasive Continuous Glucose Monitor Product
Table 144. Roche Recent Developments
Table 145. LifeScan, Inc. Corporation Information
Table 146. LifeScan, Inc. Description and Major Businesses
Table 147. LifeScan, Inc. Non-invasive Continuous Glucose Monitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 148. LifeScan, Inc. Non-invasive Continuous Glucose Monitor Product
Table 149. LifeScan, Inc. Recent Developments
Table 150. Insulet Corporation Corporation Information
Table 151. Insulet Corporation Description and Major Businesses
Table 152. Insulet Corporation Non-invasive Continuous Glucose Monitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 153. Insulet Corporation Non-invasive Continuous Glucose Monitor Product
Table 154. Insulet Corporation Recent Developments
Table 155. Panasonic Corporation Information
Table 156. Panasonic Description and Major Businesses
Table 157. Panasonic Non-invasive Continuous Glucose Monitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 158. Panasonic Non-invasive Continuous Glucose Monitor Product
Table 159. Panasonic Recent Developments
Table 160. Echo Therapeutics Corporation Information
Table 161. Echo Therapeutics Description and Major Businesses
Table 162. Echo Therapeutics Non-invasive Continuous Glucose Monitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 163. Echo Therapeutics Non-invasive Continuous Glucose Monitor Product
Table 164. Echo Therapeutics Recent Developments
Table 165. Tandem Diabetes Care Corporation Information
Table 166. Tandem Diabetes Care Description and Major Businesses
Table 167. Tandem Diabetes Care Non-invasive Continuous Glucose Monitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 168. Tandem Diabetes Care Non-invasive Continuous Glucose Monitor Product
Table 169. Tandem Diabetes Care Recent Developments
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Non-invasive Continuous Glucose Monitor Distributors List
Table 173. Non-invasive Continuous Glucose Monitor Customers List
Table 174. Non-invasive Continuous Glucose Monitor Market Trends
Table 175. Non-invasive Continuous Glucose Monitor Market Drivers
Table 176. Non-invasive Continuous Glucose Monitor Market Challenges
Table 177. Non-invasive Continuous Glucose Monitor Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Non-invasive Continuous Glucose Monitor Product Picture
Figure 2. Global Non-invasive Continuous Glucose Monitor Market Share by Type in 2020 & 2027
Figure 3. Wearable Product Picture
Figure 4. Not wearable Product Picture
Figure 5. Global Non-invasive Continuous Glucose Monitor Market Share by Application in 2020 & 2027
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Other
Figure 9. Non-invasive Continuous Glucose Monitor Report Years Considered
Figure 10. Global Non-invasive Continuous Glucose Monitor Sales 2016-2027 (K Units)
Figure 11. Global Non-invasive Continuous Glucose Monitor Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Non-invasive Continuous Glucose Monitor Revenue 2016-2027 (US$ Million)
Figure 13. Global Non-invasive Continuous Glucose Monitor Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 14. Global Non-invasive Continuous Glucose Monitor Sales Market Share by Region (2016-2021)
Figure 15. Global Non-invasive Continuous Glucose Monitor Sales Market Share by Region (2022-2027)
Figure 16. North America Non-invasive Continuous Glucose Monitor Sales YoY (2016-2027) & (K Units)
Figure 17. North America Non-invasive Continuous Glucose Monitor Revenue YoY (2016-2027) & (US$ Million)
Figure 18. Europe Non-invasive Continuous Glucose Monitor Sales YoY (2016-2027) & (K Units)
Figure 19. Europe Non-invasive Continuous Glucose Monitor Revenue YoY (2016-2027) & (US$ Million)
Figure 20. Asia-Pacific Non-invasive Continuous Glucose Monitor Sales YoY (2016-2027) & (K Units)
Figure 21. Asia-Pacific Non-invasive Continuous Glucose Monitor Revenue YoY (2016-2027) & (US$ Million)
Figure 22. Latin America Non-invasive Continuous Glucose Monitor Sales YoY (2016-2027) & (K Units)
Figure 23. Latin America Non-invasive Continuous Glucose Monitor Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Middle East & Africa Non-invasive Continuous Glucose Monitor Sales YoY (2016-2027) & (K Units)
Figure 25. Middle East & Africa Non-invasive Continuous Glucose Monitor Revenue YoY (2016-2027) & (US$ Million)
Figure 26. The Top 10 and Top 5 Players Market Share by Non-invasive Continuous Glucose Monitor Sales in 2020
Figure 27. The Top 10 and Top 5 Players Market Share by Non-invasive Continuous Glucose Monitor Revenue in 2020
Figure 28. Non-invasive Continuous Glucose Monitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 29. Global Non-invasive Continuous Glucose Monitor Sales Market Share by Type (2016-2027)
Figure 30. Global Non-invasive Continuous Glucose Monitor Revenue Market Share by Type (2016-2027)
Figure 31. Global Non-invasive Continuous Glucose Monitor Sales Market Share by Application (2016-2027)
Figure 32. Global Non-invasive Continuous Glucose Monitor Revenue Market Share by Application (2016-2027)
Figure 33. North America Non-invasive Continuous Glucose Monitor Sales Market Share by Type (2016-2027)
Figure 34. North America Non-invasive Continuous Glucose Monitor Revenue Market Share by Type (2016-2027)
Figure 35. North America Non-invasive Continuous Glucose Monitor Sales Market Share by Application (2016-2027)
Figure 36. North America Non-invasive Continuous Glucose Monitor Revenue Market Share by Application (2016-2027)
Figure 37. North America Non-invasive Continuous Glucose Monitor Sales Share by Country (2016-2027)
Figure 38. North America Non-invasive Continuous Glucose Monitor Revenue Share by Country (2016-2027)
Figure 39. United States Non-invasive Continuous Glucose Monitor Revenue (2016-2027) & (US$ Million)
Figure 40. Canada Non-invasive Continuous Glucose Monitor Revenue (2016-2027) & (US$ Million)
Figure 41. Europe Non-invasive Continuous Glucose Monitor Sales Market Share by Type (2016-2027)
Figure 42. Europe Non-invasive Continuous Glucose Monitor Revenue Market Share by Type (2016-2027)
Figure 43. Europe Non-invasive Continuous Glucose Monitor Sales Market Share by Application (2016-2027)
Figure 44. Europe Non-invasive Continuous Glucose Monitor Revenue Market Share by Application (2016-2027)
Figure 45. Europe Non-invasive Continuous Glucose Monitor Sales Share by Country (2016-2027)
Figure 46. Europe Non-invasive Continuous Glucose Monitor Revenue Share by Country (2016-2027)
Figure 47. Germany Non-invasive Continuous Glucose Monitor Revenue (2016-2027) & (US$ Million)
Figure 48. France Non-invasive Continuous Glucose Monitor Revenue (2016-2027) & (US$ Million)
Figure 49. U.K. Non-invasive Continuous Glucose Monitor Revenue (2016-2027) & (US$ Million)
Figure 50. Italy Non-invasive Continuous Glucose Monitor Revenue (2016-2027) & (US$ Million)
Figure 51. Russia Non-invasive Continuous Glucose Monitor Revenue (2016-2027) & (US$ Million)
Figure 52. Asia Pacific Non-invasive Continuous Glucose Monitor Sales Market Share by Type (2016-2027)
Figure 53. Asia Pacific Non-invasive Continuous Glucose Monitor Revenue Market Share by Type (2016-2027)
Figure 54. Asia Pacific Non-invasive Continuous Glucose Monitor Sales Market Share by Application (2016-2027)
Figure 55. Asia Pacific Non-invasive Continuous Glucose Monitor Revenue Market Share by Application (2016-2027)
Figure 56. Asia Pacific Non-invasive Continuous Glucose Monitor Sales Share by Region (2016-2027)
Figure 57. Asia Pacific Non-invasive Continuous Glucose Monitor Revenue Share by Region (2016-2027)
Figure 58. China Non-invasive Continuous Glucose Monitor Revenue (2016-2027) & (US$ Million)
Figure 59. Japan Non-invasive Continuous Glucose Monitor Revenue (2016-2027) & (US$ Million)
Figure 60. South Korea Non-invasive Continuous Glucose Monitor Revenue (2016-2027) & (US$ Million)
Figure 61. India Non-invasive Continuous Glucose Monitor Revenue (2016-2027) & (US$ Million)
Figure 62. Australia Non-invasive Continuous Glucose Monitor Revenue (2016-2027) & (US$ Million)
Figure 63. Taiwan Non-invasive Continuous Glucose Monitor Revenue (2016-2027) & (US$ Million)
Figure 64. Indonesia Non-invasive Continuous Glucose Monitor Revenue (2016-2027) & (US$ Million)
Figure 65. Thailand Non-invasive Continuous Glucose Monitor Revenue (2016-2027) & (US$ Million)
Figure 66. Malaysia Non-invasive Continuous Glucose Monitor Revenue (2016-2027) & (US$ Million)
Figure 67. Latin America Non-invasive Continuous Glucose Monitor Sales Market Share by Type (2016-2027)
Figure 68. Latin America Non-invasive Continuous Glucose Monitor Revenue Market Share by Type (2016-2027)
Figure 69. Latin America Non-invasive Continuous Glucose Monitor Sales Market Share by Application (2016-2027)
Figure 70. Latin America Non-invasive Continuous Glucose Monitor Revenue Market Share by Application (2016-2027)
Figure 71. Latin America Non-invasive Continuous Glucose Monitor Sales Share by Country (2016-2027)
Figure 72. Latin America Non-invasive Continuous Glucose Monitor Revenue Share by Country (2016-2027)
Figure 73. Mexico Non-invasive Continuous Glucose Monitor Revenue (2016-2027) & (US$ Million)
Figure 74. Brazil Non-invasive Continuous Glucose Monitor Revenue (2016-2027) & (US$ Million)
Figure 75. Argentina Non-invasive Continuous Glucose Monitor Revenue (2016-2027) & (US$ Million)
Figure 76. Colombia Non-invasive Continuous Glucose Monitor Revenue (2016-2027) & (US$ Million)
Figure 77. Middle East and Africa Non-invasive Continuous Glucose Monitor Sales Market Share by Type (2016-2027)
Figure 78. Middle East and Africa Non-invasive Continuous Glucose Monitor Revenue Market Share by Type (2016-2027)
Figure 79. Middle East and Africa Non-invasive Continuous Glucose Monitor Sales Market Share by Application (2016-2027)
Figure 80. Middle East and Africa Non-invasive Continuous Glucose Monitor Revenue Market Share by Application (2016-2027)
Figure 81. Middle East and Africa Non-invasive Continuous Glucose Monitor Sales Share by Country (2016-2027)
Figure 82. Middle East and Africa Non-invasive Continuous Glucose Monitor Revenue Share by Country (2016-2027)
Figure 83. Turkey Non-invasive Continuous Glucose Monitor Revenue (2016-2027) & (US$ Million)
Figure 84. Saudi Arabia Non-invasive Continuous Glucose Monitor Revenue (2016-2027) & (US$ Million)
Figure 85. UAE Non-invasive Continuous Glucose Monitor Revenue (2016-2027) & (US$ Million)
Figure 86. Non-invasive Continuous Glucose Monitor Value Chain
Figure 87. Non-invasive Continuous Glucose Monitor Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed